Discovery Could Increase Efficacy of Promising Cystic Fibrosis Drug
Thursday, March 21, 2013 - 13:30
in Health & Medicine
University of Missouri researchers believe they have found exactly how Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, works and how to improve its effectiveness in the future.